Rg. Hempelmann et al., Threshold concentrations of endothelin-1: The effects on contractions induced by 5-hydroxytryptamine in isolated rat cerebral and mesenteric arteries, PHARM TOX, 85(3), 1999, pp. 115-122
This study compares the effects of threshold concentrations of endothelin-1
in isolated rat basilar arteries with those in mesenteric arterial branche
s and investigates the mechanisms of inhibitory and potentiating endothelin
-1-effects. In basilar arteries, endothelin-1 reduces the contractions indu
ced by 5-hydroxytryptamine (5-HT), by the thromboxane A(2) agonist U46619,
and by vasopressin. The inhibitory effect of endothelin-l on the contractio
n induced by 5-HT is abolished by deendothelialization, by the endothelin E
TB receptor antagonist RES 701-1, by indomethacin, or by glibenclamide. In
mesenteric arteries, endothelin-1 potentiates the contractile effects of 5-
HT, U46619, and vasopressin. The potentiation of the contractile effect ind
uced by 5-HT is only somewhat modified by deendothelialization, but abolish
ed by the thromboxane A(2) receptor antagonists GR32191 and ridogrel. U4661
9 potentiates the 5-HT-effect in mesenteric arteries. Thus, though the cont
ractile endothelin ETA receptors were not blocked, threshold concentrations
of endothelin-1 inhibited contractile effects in the rat basilar artery vi
a activation of endothelial ETB receptors. Prostaglandins and ATP-sensitive
K+ channels are involved in this inhibitory action. In contrast, endotheli
n-1 potentiates contractile actions in mesenteric arteries via the release
of endogeneous thromboxane A(2) from non-endothelial cells. The study point
s out the completely different role of the endothelium in combined effects
of endothelin-1 between cerebral and mesenteric arteries.